Atlas Trials

A Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Activity of Very Low Dose-Glucagon in Subjects With Type 1 Diabetes Mellitus

Clinical trial NCT00304538 · COMPLETED

Trial details

NCT number
NCT00304538
Sponsor
DiObex
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Type 1 Diabetes
Start date
2006-03-01
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.